Top 12 alternative sites to alprolix.com
-
idelvion.com
-
rebinyn.com
-
tretten.com
-
rixubis.com
-
alprolixpro.com
-
afstyla.com
-
novoeightpro.com
-
alphanate.com
-
eloctatepro.com
-
hemlibra.com
-
eloctate.com
-
novosevenrt.com
Factor IX Therapy for Hemophilia B | IDELVION coagulation factor IX (recombinant), albumin fusion protein
IDELVION is the only extended half-life Factor IX therapy that delivers zero bleeds, 14-day dosing and 20% FIX trough levels for hemophilia B.
Take Control of Hemophilia B | Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated
Take control of Hemophilia B with Rebinyn®, an injectable treatment replacing clotting factor 9. Learn why Rebinyn® is different, how it works, and more. Read important safety & prescribing info.
Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]) | Home
Learn about treatment with Tretten® (Coagulation Factor XIII A-Subunit [Recombinant]), the only recombinant therapy for congenital factor XIII A-subunit deficiency.
RIXUBIS [Coagulation Factor IX (Recombinant)]
Please see RIXUBIS [Coagulation Factor IX (Recombinant)] Detailed Important Risk Information and Full Prescribing Information.
ALPROLIX® Professional Site Homepage | EHL rFIX therapy
ALPROLIX® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] keeps the future in mind for your patients with hemophilia B
Factor VIII Therapy for Hemophilia A | AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
Learn about AFSTYLA, a Factor VIII therapy that provides long-lasting bleed protection for people with hemophilia A. Also explore how to get a free trial.
Novoeight® (Antihemophilic Factor [Recombinant]) | HCP Website
Novoeight® (Antihemophilic Factor [Recombinant]) is indicated for use in adults and children with hemophilia A for control and prevention of bleeding, among other indications. See Prescribing Info.
ALPHANATE® Hemophilia A and von Willebrand Disease Treatment
Learn about ALPHANATE® (antihemophilic factor/von Willebrand factor complex [human]), a hemophilia A and von Willebrand disease treatment.
Home | ELOCTATE®
Learn more about ELOCTATE® [Antihemophilia factor (recombinant), Fc fusion protein].
HEMLIBRA® (emicizumab-kxwh) | Hemophilia A Treatment
Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment approved for people with hemophilia A with or without factor VIII inhibitors. See full safety and BOXED WARNING.
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]
Count the reasons to choose ELOCTATE
Official Patient Website for NovoSeven® RT (coagulation Factor VIIa, recombinant)
NovoSeven® RT (coagulation Factor VIIa, recombinant) has a long history of helping people control their bleeds effectively. Learn how it can help you. See Safety Information and Prescribing Information.
